Pantothenate kinase-associated neurodegeneration (PKAN) is a rare condition associated with severe protrusive lingual dystonia, a form of oromandibular dystonia. Dental appliance therapy has been described for oromandibular dystonia however there is a lack of literature regarding its application specifically to PKAN. In this report, the authors describe the use of an appliance in conjunction with botulinum toxin injections for the symptomatic treatment of this condition. A satisfactory outcome is achieved which suggests this technique may be of use to other clinicians.
INTRODUCTION
Oromandibular dystonias are described by Tan et al as consisting of involuntary spasms of masticatory, lingual and pharyngeal muscles resulting in jaw closing, jaw opening, jaw deviation or a combination of these movements. Most commonly the condition is idiopathic. 1 PKAN is a rare autosomal recessive disease caused by mutation to the PANK2 gene affecting approximately 1-3 per million. 2 Iron accumulation in the basal ganglia forms the classic "eye of the tiger" sign on MRI. 2 PKAN is characterized by progressive dystonia and spasticity with an initial onset in the first decade of life. Severe protrusive lingual dystonia is characteristic of the condition. 3 This can cause significant distress for both patient and carers and can result in trauma to the lingual tissues with occasional severe consequences. [3] [4] [5] Previously trialed treatments for dystonia associated with PKAN include iron chelation therapy, anticholinergics, baclofen, and deepbrain stimulation amongst others. Botulinum toxin injection has received positive reports for PKAN and is a mainstay of treatment of nonsyndromal oromandibular dystonias. 4, 6, 7 Full dental clearance is a dramatic but sometimes utilized treatment option. 8 Dental appliance therapy has been used successfully in the treatment of oromandibular dystonias. [9] [10] [11] © 2018 Special Care Dentistry Association and Wiley Periodicals, Inc.
Typically, these appliances involve the use of posterior occlusal rests which may function as a "sensory trick" hypothesized to force the neuromuscular mechanism that causes the dystonia to temporarily cease. 6, 10 Literature exists describing their use in patients with isolated oromandibular dystonias only. 6, 10 No previous literature exists describing the use of dental appliance therapy in PKAN patients.
Case report
The authors describe a 23-year-old male PKAN patient attending the maxillofacial outpatients department of a major tertiary referral center. The patient had been referred by his neurologist with the primary complaint of severe protrusive lingual dystonia, refractory to pharmacological management, which included baclofen and clonazepam.
Onset of PKAN symptoms had begun at age 3. Currently the patient was PEG fed, unable to speak, and had a prior history of botulinium toxin A injections to his hands for dystonia, which had given some improvement in symptoms.
The patient exhibited a protrusive lingual dystonia that was active throughout the waking hours and prevented detailed dental examination. The patient's lingual dystonia was accompanied by clenching of the teeth which was severe enough to cause superficial trauma to the tongue on multiple occasions.
F I G U R E 1 Photograph of appliance in situ
The dystonia was upsetting for the patient (who retained full cognitive function) as well as his family.
General anesthesia was used to facilitate oral examination and the taking of dental impressions, bite registration, and face-bow measurements. It was evident the patient exhibited a pronounced anterior open bite, likely secondary to his tongue thrust.
A maxillary dental appliance was fabricated from acrylic (see Figure 1) . It consisted of coverage of all upper maxillary teeth with a large anterior bite block extending from canine to canine allowing teeth previously in open bite to contact the appliance. It was theorized the bite block, in conjunction with the patient's tendency to clench would prevent protrusion of the tongue.
Prior to the fitting of the appliance the patient received, from his neurologist, 12.5 units of botulinum toxin A injection bilaterally to the tongue. It was noted at the time of fitting that this had the desired effect of somewhat reducing lingual tone as well as the extent of protrusion.
The appliance was fitted without complication and the patient advised to wear it fulltime during the day (see Figure 2) . Upon review at 6 months, the patient is tolerating the appliance well and in fact prefers to wear the appliance fulltime. Family attending with the patient indicate it has achieved the desired effect of preventing lingual protrusion and trauma.
DISCUSSION
The lingual dystonia seen in PKAN is notoriously difficult to treat. 3, 4 Previously documented therapies for the dystonia and its resulting lingual trauma include dental extractions, bite blocks and botulinium toxin A injection. Additionally, therapies such as baclofen, anticholinergics and deep brain stimulation are used to treat the generalized dystonias of PKAN and may have some role in lingual dystonia. 2 All of these therapies are symptomatic in nature. Iron chelation is F I G U R E 2 Photograph of patient with appliance in situ the only disease modifying therapy and this is of questionable efficacy as a monotherapy. 12 Dental appliances used for treatment of oromandibular dystonias typically involve posterior occlusal rests designed to provide sensory feedback via a hypothesized proprioceptive mechanism that is not well understood. 10 Given most oromandibular dystonias are not associated with syndromic patients it is unclear whether this same mechanism could be exploited for use in PKAN.
The author's hypothesize the effectiveness of the appliance described in this report is primarily due to its effect as a restrictive device for the tongue. It achieves this via a combination of: (1) being a custom fitted, rigid appliance that locks onto the upper teeth and (2) due to the patient's clenching of the mandible, which ensures robust retention of the device despite vigorous lingual protrusion. Additionally, the authors feel the botulinium toxin A injection greatly assisted the patient to adapt to daily use of the device.
This appliance could be easily fabricated by a dentist working with a dental technician and caries the advantage of potentially reducing the need for pharmacological management with its associated side effects. The authors suggest clinicians caring for PKAN patients consider dental appliance therapy as an adjunct if lingual protrusion is a concern of the patient or family. Further investigation is needed to establish dental appliance therapy as a first line treatment.
The follow up interval of 6 months described in this case report does not give insight into the long-term viability of this therapy. The authors will be highly interested to see how the patient adapts to the appliance once any residual effect of the botulinium toxin A has abated. It is unclear at this stage whether the patient will require repeated applications of botulinum toxin A. If this is the case, it is not unfeasible given the patient is regularly injected at other sites by his neurologist.
CONCLUSION
Dental appliance therapy may be a worthwhile treatment option for PKAN patients suffering from protrusive lingual dystonia when used in conjunction with botulinium toxin A injection.
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